Why subscribe?

Subscribe to get full access to the newsletter and website. Never miss an update.

Stay up-to-date

You won’t have to worry about missing anything. Every new edition of the newsletter goes directly to your inbox.

Join the crew

Be part of a community of people who share your interests.

To find out more about the company that provides the tech for this newsletter, visit Substack.com.

Subscribe to Late Stage Insider

We cover all aspects of late stage drug development. Our focus is on oncology, and all key figures in the clinical trial race to commercialisation.

People

CEO at Yendou. On a mission to connect the world of oncology clinical research to help Pharma/biotech & CRO companies deliver medical innovation faster to those with cancer.